Paul Streck is EVP, Head of R&D of PepGen Inc.. Currently has a direct ownership of 27,805 shares of PEPG, which is worth approximately $42,541. The most recent transaction as insider was on May 30, 2025, when has been sold 8,375 shares (Common Stock) at a price of $1.24 per share, resulting in proceeds of $10,385. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.8K
43.1% 3M change
n/a 12M change
Total Value Held $42,541

PAUL STRECK Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2025
BUY
Open market or private purchase
$10,385 $1.24 p/Share
8,375 Added 23.15%
27,805 Common Stock
Mar 03 2025
BUY
Grant, award, or other acquisition
-
19,430 Added 50.0%
19,430 Common Stock

Also insider at

ALBO
ALBIREO PHARMA, INC. Healthcare
PS

Paul Streck

EVP, Head of R&D
Boston, MA

Track Institutional and Insider Activities on PEPG

Follow PepGen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PEPG shares.

Notify only if

Insider Trading

Get notified when an Pep Gen Inc. insider buys or sells PEPG shares.

Notify only if

News

Receive news related to PepGen Inc.

Track Activities on PEPG